Completed PHASE1 INTERVENTIONAL 4-arm NCT00862901

Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma (CLIPT)

A Phase I Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) for Patients Failing Radiation Therapy

Sponsor: Axcan Pharma

Interventions CLIPT patch

Updated 6 times since 2017 Last updated: Sep 23, 2011 Started: Jan 31, 2009 Primary completion: Jan 31, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00862901, this PHASE1 trial focuses on Breast Cancer and Skin Cancer and remains completed. Sponsored by Axcan Pharma, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Axcan Pharma
Susan G. Komen Breast Cancer Foundation
Tufts Medical Center

Data source: Tufts Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States